Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer

George R. Blumenschein, Ulrich Gatzemeier, Frank Fossella, David J. Stewart, Lisa Cupit, Frank Cihon, James O'Leary, Martin Reck

Research output: Contribution to journal › Article › peer-review

186 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences